Skip to main content
OpenTrials

Clinical trial condition

Hormone Receptor Positive (HR+), HER2-negative Breast Cancer

Explore clinical trials studying Hormone Receptor Positive (HR+), HER2-negative Breast Cancer. Study availability and eligibility vary by location and protocol.

2 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Hormone Receptor Positive (HR+), HER2-negative Breast Cancer trial results

Recruiting

Predicting clinicAL outcoMes During First-line CDK4/6 Inhibitors Plus Endocrine Therapy in Patients With Advanced Hormone REceptor-poSitive HER2-negative Breast Cancer: the Retrospective-prospective Multicenter Italian PALMARES-2 Study

NCT06805812

Conditions
Abemaciclib, Breast Adenocarcinoma, Breast Cancer, +46 more
Locations
  • Centro di Riferimento Oncologico IRCCS Aviano, Italy
  • Azienda Socio Sanitaria Territoriale degli Spedali Civili Brescia, Italy
  • Humanitas Istituto Clinico Catanese Catania, Italy
  • ASST Lariana - Ospedale Sant'Anna Como, Italy
View all 24 locations
View Trial Details
Active, Not Recruiting

Pre-op Pembro + Radiation Therapy in Breast Cancer (P-RAD)

NCT04443348

Conditions
Biopsy-proven, Positive Lymph Node(s), Breast Diseases, Breast Neoplasms, +7 more
Locations
  • Sibley Memorial Hospital Washington D.C., District of Columbia, United States
  • Johns Hopkins Baltimore, Maryland, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details

Related conditions